Table 1.
PLCε and YAP in PCa tissues and linicopathological parameters
| Characteristics | No. specimens (%) | PLCε staining | YAP staining | ||||
|---|---|---|---|---|---|---|---|
|
|
|
||||||
| Positive | Negative | P value | Positive | Negative | P value | ||
| Total | 58 (100) | 43 (74.1) | 15 (25.9) | 48 (82.8) | 10 (17.2) | ||
| Age (year) | |||||||
| <60 | 17 (29.3) | 13 (22.4) | 4 (6.9) | 0.536 | 15 (25.9) | 2 (3.4) | 0.385 |
| ≥60 | 41 (70.7) | 30 (51.7) | 11 (19.0) | 33 (56.9) | 8 (13.8) | ||
| Histological stage | |||||||
| Ta-T2 | 20 (34.5) | 11 (19.0) | 9 (15.5) | 0.019* | 13 (22.4) | 7 (12.1) | 0.014* |
| T3-T4 | 38 (65.5) | 32 (55.1) | 6 (10.4) | 35 (60.4) | 3 (5.1) | ||
| Gleason score | |||||||
| <7 | 25 (43.1) | 15 (25.8) | 10 (17.3) | 0.033* | 17 (29.3) | 8 (13.8) | 0.012* |
| ≥7 | 33 (56.9) | 28 (48.3) | 5 (8.6) | 31 (53.5) | 2 (3.4) | ||
Note. PCa: prostate cancer. Statistical method: χ2 test. The bold entries represent statistically significant differences.
*
P<0.05;
**P<0.01;
***P<0.001.